Insider · CIK 0001397906

Cha Albert

Reports to the SEC for 9 companies · HELLERUP

sec.gov

Transactions

Companies

Filings

CIK

0001397906

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-26	KalVista Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-09-11	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$7.88	+$94.6K	18,000
2023-09-11	KalVista Pharmaceuticals, Inc.S Sale	Director	SSale	−18K sh	$10.50	−$189K	0
2023-09-11	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$6.71	+$40.3K	6,000
2023-09-11	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	0
2023-09-11	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2022-10-13	KalVista Pharmaceuticals, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-09-30	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-10-30	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+68.3K sh	$17.17	+$1.17M	1,090,748
2020-10-30	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+47.4K sh	$17.34	+$822K	1,138,179
2020-10-01	KalVista Pharmaceuticals, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2019-10-02	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2019-07-29	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+24.7K sh	$17.13	+$424K	1,022,493
2019-07-29	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+5,137 sh	$17.13	+$88K	124,566
2019-07-26	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+21.9K sh	$16.83	+$369K	997,763
2019-07-26	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+4,558 sh	$16.83	+$76.7K	119,429
2019-07-19	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+49.7K sh	$17.84	+$886K	975,821
2019-07-19	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+10.3K sh	$17.68	+$182K	114,871
2019-07-17	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+220 sh	$16.93	+$3,724.006	104,551
2019-07-17	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+1,060 sh	$16.97	+$18K	926,141
2018-10-03	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2018-09-10	KalVista Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+1.06M sh	$17.00	+$18M	1,359,149
2018-05-01	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2018-03-14	Biohaven Pharmaceutical Holding Co Ltd.A Award	Director	AAward	+72.7K sh	$27.50	+$2M	2,049,545
2018-01-29	YARWYarrow Bioscience, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−342K sh	—	—	0
2018-01-29	YARWYarrow Bioscience, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−6.34M sh	—	—	0
2018-01-29	YARWYarrow Bioscience, Inc.C Conversion	Director	CConversion	+2.35M sh	—	—	2,606,982
2018-01-29	YARWYarrow Bioscience, Inc.C Conversion	Director	CConversion	+324K sh	—	—	359,992
2018-01-29	YARWYarrow Bioscience, Inc.C Conversion	Director	CConversion	+918K sh	—	—	3,524,541
2018-01-29	YARWYarrow Bioscience, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−875K sh	—	—	0
2018-01-29	YARWYarrow Bioscience, Inc.C Conversion	Director	CConversion	+127K sh	—	—	486,695
2018-01-29	YARWYarrow Bioscience, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−2.48M sh	—	—	0
2018-01-25	YARWYarrow Bioscience, Inc.P Purchase	Director	PPurchase	+258K sh	$17.00	+$4.39M	258,432
2018-01-25	YARWYarrow Bioscience, Inc.P Purchase	Director	PPurchase	+35.7K sh	$17.00	+$607K	35,686
2017-09-27	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2017-05-09	Biohaven Pharmaceutical Holding Co Ltd.Series A Preferred SharesC Conversion	Director	CConversion	−1.51M sh	—	—	0
2017-05-09	Biohaven Pharmaceutical Holding Co Ltd.P Purchase	Director	PPurchase	+470K sh	$17.00	+$7.99M	1,976,818
2017-05-09	Biohaven Pharmaceutical Holding Co Ltd.C Conversion	Director	CConversion	+1.51M sh	—	—	1,506,818
2017-03-23	KalVista Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2016-06-29	ACRSAclaris Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,632 sh	—	—	6,632
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−1.82M sh	—	—	0
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−1.38M sh	—	—	0
2015-10-13	ACRSAclaris Therapeutics, Inc.C Conversion	Director	CConversion	+3.43M sh	—	—	3,736,852
2015-10-13	ACRSAclaris Therapeutics, Inc.P Purchase	Director	PPurchase	+455K sh	$11.00	+$5M	4,191,397
2015-10-13	ACRSAclaris Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−8.65M sh	—	—	0
2015-10-07	ACRSAclaris Therapeutics, Inc.P Purchase	Director	PPurchase	+13.4K sh	$11.00	+$147K	303,206
2015-07-21	Sierra Oncology, Inc.Series D Preferred StockC Conversion	Director	CConversion	−2.06M sh	—	—	0
2015-07-21	Sierra Oncology, Inc.C Conversion	Director	CConversion	+2.06M sh	—	—	2,064,308
2015-07-21	Sierra Oncology, Inc.C Conversion	Director	CConversion	+45K sh	—	—	2,109,299
2015-07-21	Sierra Oncology, Inc.J Other	Director	JOther	+107K sh	$5.21	+$556K	2,215,946

Recent filings

Accepted (ET)
Sep 284
Cha Albert0001209191-23-050750
SEC(opens sec.gov)
Sep 134
Cha Albert0001209191-23-049268
SEC(opens sec.gov)
Oct 174
Cha Albert0001209191-22-053875
SEC(opens sec.gov)
Oct 14
Cha Albert0001209191-21-058484
SEC(opens sec.gov)
Nov 34
Cha Albert0001209191-20-056790
SEC(opens sec.gov)
Oct 24
Cha Albert0001209191-20-053393
SEC(opens sec.gov)
Oct 34
Cha Albert0001567619-19-019235
SEC(opens sec.gov)
Jul 304
Cha Albert0001567619-19-015484
SEC(opens sec.gov)
Jul 194
Cha Albert0001567619-19-015022
SEC(opens sec.gov)

Companies

Address

C/O ASCENDIS PHARMA A/S TUBORG BOULEVARD 12

HELLERUP, DK-2900